NCT05489211 2026-03-19Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)AstraZenecaPhase 2 Recruiting454 enrolled
NCT04956640 2025-09-25Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)Eli Lilly and CompanyPhase 1/2 Recruiting540 enrolled
NCT03314935 2025-08-12A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid TumorsIncyte CorporationPhase 1/2 Completed149 enrolled 35 charts